Why Celyad Oncology (CYAD) Shares Are Surging Today
[ad_1] The FDA has lifted the clinical hold on Celyad Oncology SA’s CYAD CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company made changes to the eligibility criteria for the trial. “We remain…